ClinicalTrials.gov
ClinicalTrials.gov Menu

Folic Acid Supplementation in Phenytoin Induced Gingival Overgrowth (PIGO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00781196
Recruitment Status : Completed
First Posted : October 28, 2008
Last Update Posted : August 4, 2009
Sponsor:
Information provided by:
All India Institute of Medical Sciences, New Delhi

Brief Summary:
Phenytoin, a common anti-seizure drug, leads to cosmetically unacceptable side effect of gingival overgrowth in a significant number of patients. There is some evidence of therapeutic effect of folic acid in cases of established phenytoin induced gingival overgrowth. In this study, the aim is to study the prospective preventive effect of low dose oral folic acid supplementation on phenytoin induced gingival overgrowth in epileptic children.

Condition or disease Intervention/treatment Phase
Gingival Overgrowth Drug: folic acid Drug: placebo Phase 3

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of Low Dose Oral Folic Acid Supplementation on Phenytoin Induced Gingival Overgrowth: A Randomized Double Blind Controlled Trial.
Study Start Date : May 2008
Actual Primary Completion Date : January 2009
Actual Study Completion Date : July 2009

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: 1
Oral folic acid
Drug: folic acid
capsule 0.5 mg once a day

Placebo Comparator: 2
placebo
Drug: placebo
capsule, once a day




Primary Outcome Measures :
  1. Occurrence of any grade of overgrowth in 2 groups after 6 mo of phenytoin therapy [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Occurrence of grade > 2 hyperplasia at the end of 6 mo [ Time Frame: 6 months ]
  2. Time to occurrence of grade > 2 overgrowth [ Time Frame: open ]
  3. Correlation between following and occurrence of grade > 2 overgrowth *phenytoin dose (in mg/kg/d) *serum phenytoin levels *plaque index [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age: 6-15 yr
  • Started on phenytoin within 1 mo of enrollment

Exclusion Criteria:

  • Not willing to participate
  • On other folic acid antagonists e.g. anti-neoplastic drugs for >/= 2 wks during last 3 months
  • Pre-existing gingival over-growth due to other cause

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00781196


Locations
India
All India Institute of Medical Sciences
New Delhi, Delhi, India, 110029
Sponsors and Collaborators
All India Institute of Medical Sciences, New Delhi

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Ravindra Arya, All India Institute of Medical Sciences, New Delhi
ClinicalTrials.gov Identifier: NCT00781196     History of Changes
Other Study ID Numbers: PIGO
First Posted: October 28, 2008    Key Record Dates
Last Update Posted: August 4, 2009
Last Verified: August 2009

Keywords provided by All India Institute of Medical Sciences, New Delhi:
phenytoin
gum hyperplasia
phenytoin induced gingival overgrowth
plaque index
gingival overgrowth grade

Additional relevant MeSH terms:
Gingival Overgrowth
Gingival Diseases
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Folic Acid
Vitamin B Complex
Phenytoin
Hematinics
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs
Anticonvulsants
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cytochrome P-450 CYP1A2 Inducers
Cytochrome P-450 Enzyme Inducers